Evidence map›Paper›PMID 39350827›Full record

ReviewCureus2024

Effectiveness of Coenzyme Q10 Supplementation in Statin-Induced Myopathy: A Systematic Review.

Khoula Ahmad, Naelijwa J Manongi, Ramkumar Rajapandian, Sajida Moti Wala, Esraa M Al Edani, Essa A Samuel, Ana P Arcia Franchini

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Lipid lowering in coronary artery disease - not just statins.Clinical medicine (London, England) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Coenzyme Q10 and Xenobiotic Metabolism: An Overview.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khoula AhmadInternal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Naelijwa J ManongiFamily Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Ramkumar RajapandianTrauma and Orthopedics, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Sajida Moti WalaInternal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Esraa M Al EdaniDermatology, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Essa A SamuelPhysical Medicine and Rehabilitation, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Ana P Arcia FranchiniResearch, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are among the most widely prescribed drugs for treating dyslipidemia and reducing the incidence of heart disease and stroke. However, they come with a wide range of side effects, from myopathy to necrotizing rhabdomyolysis, as well as diabetes, hepatotoxicity, and sleep problems. The most common side effect of statins is statin-induced myopathy, often leading to discontinuation of statin therapy and noncompliance in many patients. This study aims to assess the effectiveness of coenzyme Q10 (CoQ10) supplementation as a treatment for patients with statin-induced myopathy. This systematic review was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement. Relevant studies were identified through searches of Medline, PMC, PubMed, Science Direct, and Google Scholar. Only randomized control trials and meta-analyses of oral CoQ10 supplementation versus placebo in adults with statin-associated myalgia were included. The risk of bias was assessed using the Cochrane Risk of Bias tool (The Cochrane Collaboration, London, England, UK) and the measurement tool for the "assessment of multiple systematic reviews" (AMSTAR tool). Out of 5,000 records identified, only five were selected for this review: one meta-analysis and four randomized controlled trials. All of these studies were conducted between 2010 and 2023, involving a total of 800 patients. All randomized controlled trials showed improvement in statin-associated myopathy with CoQ10 supplementation, along with or without a reduced dosage of statins, without any notable side effects of CoQ10. Therefore, it can be deduced that CoQ10 supplementation significantly ameliorates statin-induced musculoskeletal symptoms.

Indexed as

coenzyme q10 (coq10)hmg-coa reductase inhibitorsmusculoskeletal disorderstatinsubiquinone

Identifiers

PMID39350827
PMCPMC11441719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.